Show
Sort by
-
- Journal Article
- A1
- open access
Transport by circulating myeloid cells drives liposomal accumulation in inflamed synovium
-
- Journal Article
- A1
- open access
Nanobody-mediated SPECT/CT imaging reveals the spatiotemporal expression of programmed death-ligand 1 in response to a CD8+ T cell and iNKT cell activating mRNA vaccine
-
Fluorine MR imaging probes dynamic migratory profiles of perfluorocarbon-loaded dendritic cells after streptozotocin-induced inflammation
-
- Journal Article
- A1
- open access
Immunopeptidomics-based design of mRNA vaccine formulations against Listeria monocytogenes
-
- Journal Article
- A1
- open access
The dawn of mRNA vaccines : the COVID-19 case
-
- Journal Article
- A1
- open access
mRNA in cancer immunotherapy : beyond a source of antigen
-
- Journal Article
- A1
- open access
mRNA-lipid nanoparticle COVID-19 vaccines : structure and stability
-
- Journal Article
- A1
- open access
Strategies for controlling the innate immune activity of conventional and self-amplifying mRNA therapeutics : getting the message across
-
- Journal Article
- A4
- open access
Covipendium : information available to support the development of medical countermeasures and interventions against COVID-19
-
- Journal Article
- A1
- open access
mRNA encoding a bispecific single domain antibody construct protects against influenza A virus infection in mice
-
- Journal Article
- A1
- open access
Intracellular delivery of mRNA in adherent and suspension cells by vapor nanobubble photoporation
-
- Journal Article
- A1
- open access
Longitudinal in vivo assessment of host-microbe interactions in a murine model of pulmonary aspergillosis
-
- PhD Thesis
- open access
Design of messenger RNA lipid nanoparticles for cancer immunotherapy
(2019) -
- Journal Article
- A1
- open access
Broadening the message : a nanovaccine co-loaded with messenger RNA and α-GalCer induces antitumor immunity through conventional and natural killer T cells
-
Challenges for labeling and longitudinal tracking of adoptively transferred autoreactive T lymphocytes in an experimental type-1 diabetes model
-
- Journal Article
- A1
- open access
Three decades of messenger RNA vaccine development
-
Optimized messenger RNA immunolipoplexes for cancer immunotherapy : balancing immunogenicity and adjuvancy
-
Co-delivery of nucleoside-modified mRNA and TLR agonists for cancer immunotherapy : restoring the immunogenicity of immunosilent mRNA
-
- Journal Article
- A2
- open access
Particle-mediated intravenous delivery of antigen mRNA results in strong antigen-specific T-cell responses despite the induction of type I interferon
-
Immunogenic mRNA nanoparticles for dendritic cell-based cancer vaccination